|
English
|
正體中文
|
简体中文
|
Items with full text/Total items : 17933/22952 (78%)
Visitors : 7314102
Online Users : 219
|
|
|
Loading...
|
Please use this identifier to cite or link to this item:
https://ir.csmu.edu.tw:8080/ir/handle/310902500/24002
|
Title: | Interactive Association Between Intronic Polymorphism (rs10506151) of the LRRK2 Gene and Type 2 Diabetes on Neurodegenerative Diseases |
Authors: | Huang, MH;Liu, YF;Nfor, ON;Hsu, SY;Lin, WY;Chang, YS;Liaw, YP |
Keywords: | polymorphism;neurodegenerative disorders;diabetes;variation |
Date: | 2021 |
Issue Date: | 2022-08-05T09:46:16Z (UTC)
|
Publisher: | DOVE MEDICAL PRESS LTD |
Abstract: | Purpose: We investigated the interactive effect of rs10506151 polymorphism of the Leucine-rich repeat kinase 2 (LRRK2) gene and type 2 diabetes (T2D) on neurodegenerative disease (ND) risk. Materials and Methods: Data of 17, 927 participants in the Taiwan Biobank (TWB) assessed between 2008 and 2015 were linked to healthcare records in the National Health Insurance Research Database (NHIRD). The odd ratios (ORs) and 95% confidence intervals (CIs) for NDs were determined using logistic regression analysis. Results: There were 145 cases with NDs, and 28.28% (n = 41) of these individuals had T2D. Associations of neurodegenerative disorders with LRRK2 rs10506151 variant and T2D were not significant. The corresponding ORs (95% CI) for NDs were 1.06 (0.75-1.49) in CA/AA compared to CC individuals and 0.93 (0.63-1.39) in those with T2D compared to non-diabetic participants. However, we found evidence of a significant interaction between rs10506151 and T2D (p = 0.0073). After stratification by genotypes of rs10506151, the OR for NDs was 0.37 (CI, 0.17-0.82) in CA/AA individuals with T2D and 1.41 (0.88-2.27) in their CC counterparts. When CA/AA individuals with T2D represented the reference group, the OR (95% CI) was 1.74 (0.81-3.73) in CC individuals with no T2D, 2.47 (CI, 1.14-5.38) in CA/AA individuals with no T2D, and 2.34 (CI, 1.07-5.11) in CC individuals with T2D. Conclusion: Our data indicated that the risk of NDs was significantly lower among diabetic individuals with combined CA/AA of the LRRK2 rs10506151 variant in Taiwan. |
URI: | http://dx.doi.org/10.2147/PGPM.S316158 https://www.webofscience.com/wos/woscc/full-record/WOS:000674068400001 https://ir.csmu.edu.tw:8080/handle/310902500/24002 |
Relation: | PHARMACOGENOMICS & PERSONALIZED MEDICINE ,2021,v14 , P839-847 |
Appears in Collections: | [中山醫學大學研究成果] 期刊論文
|
Files in This Item:
File |
Description |
Size | Format | |
index.html | | 0Kb | HTML | 156 | View/Open |
|
All items in CSMUIR are protected by copyright, with all rights reserved.
|